Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression.

The $8 million renovations were funded by the Texas Legislature last session, and UTHealth is seeking an additional $12 ...

In an effort to close the gap in neurological outcomes for underserved populations, a UTHealth Houston project funded with $2.9 million from the National Institutes of Health (NIH) will engage ...

UTHealth Houston now spends more than $400 million annually on research, and many of its schools have earned national ...

A local hospital is gearing up for its first revitalization in about a decade, and it could receive more state funding this year.

Large and rare duplications and deletions in a chromosome region known as 22q11.2 , which involves genes that regulate ...

More than a decade of work with youth experiencing homelessness and HIV prevention has led to a Presidential Early Career ...

Large and rare duplications and deletions in a chromosome region known as 22q11.2 , which involves genes that regulate ...

The UTHealth Houston Institute for Implementation Science and the Texas Developmental Center for AIDS Research (Texas D-CFAR), a collaboration between Baylor College of Medicine, UTHealth Houston and ...

Male adolescents and young adults with cancer have a slightly elevated risk of having preterm birth and children with low ...

Trauma is the leading cause of death in children. There have been no large-scale clinical trials to guide the best way to resuscitate children with life-threatening bleeding from traumatic injury. The ...

Dr. Wu had previously served as assistant professor of psychiatry at UTHealth McGovern Medical School in Houston and has been involved in many years of teaching and mentorship. At UTHealth ...